The global artificial disc market size is calculated at USD 2.30 billion in 2025 and is forecasted to reach around USD 3.02 billion by 2034, accelerating at a CAGR of 3.08% from 2025 to 2034. The North America market size surpassed USD 1.25 billion in 2024 and is expanding at a CAGR of 3.12% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Disc Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Disc Market Revenue and Volume Forecast, by Type
8.1.1. Cervical Artificial Disc
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Lumber Artificial Disc
8.1.2.1. Market Revenue and Volume Forecast
9.1. Artificial Disc Market Revenue and Volume Forecast, by Material
9.1.1. Metal on Metal
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Metal on Polymer
9.1.2.1. Market Revenue and Volume Forecast
10.1. Artificial Disc Market Revenue and Volume Forecast, by Indication
10.1.1. Spinal Trauma
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Degenerative Spine Diseases
10.1.2.1. Market Revenue and Volume Forecast
11.1. Artificial Disc Market Revenue and Volume Forecast, by End-use
11.1.1. Hospitals
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Specialty Clinics
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Ambulatory Surgical Centers
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Type
12.1.2. Market Revenue and Volume Forecast, by Material
12.1.3. Market Revenue and Volume Forecast, by Indication
12.1.4. Market Revenue and Volume Forecast, by End-use
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Type
12.1.5.2. Market Revenue and Volume Forecast, by Material
12.1.5.3. Market Revenue and Volume Forecast, by Indication
12.1.5.4. Market Revenue and Volume Forecast, by End-use
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Type
12.1.6.2. Market Revenue and Volume Forecast, by Material
12.1.6.3. Market Revenue and Volume Forecast, by Indication
12.1.6.4. Market Revenue and Volume Forecast, by End-use
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Type
12.2.2. Market Revenue and Volume Forecast, by Material
12.2.3. Market Revenue and Volume Forecast, by Indication
12.2.4. Market Revenue and Volume Forecast, by End-use
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Type
12.2.5.2. Market Revenue and Volume Forecast, by Material
12.2.5.3. Market Revenue and Volume Forecast, by Indication
12.2.5.4. Market Revenue and Volume Forecast, by End-use
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Type
12.2.6.2. Market Revenue and Volume Forecast, by Material
12.2.6.3. Market Revenue and Volume Forecast, by Indication
12.2.6.4. Market Revenue and Volume Forecast, by End-use
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Type
12.2.7.2. Market Revenue and Volume Forecast, by Material
12.2.7.3. Market Revenue and Volume Forecast, by Indication
12.2.7.4. Market Revenue and Volume Forecast, by End-use
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Type
12.2.8.2. Market Revenue and Volume Forecast, by Material
12.2.8.3. Market Revenue and Volume Forecast, by Indication
12.2.8.4. Market Revenue and Volume Forecast, by End-use
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Type
12.3.2. Market Revenue and Volume Forecast, by Material
12.3.3. Market Revenue and Volume Forecast, by Indication
12.3.4. Market Revenue and Volume Forecast, by End-use
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Type
12.3.5.2. Market Revenue and Volume Forecast, by Material
12.3.5.3. Market Revenue and Volume Forecast, by Indication
12.3.5.4. Market Revenue and Volume Forecast, by End-use
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Type
12.3.6.2. Market Revenue and Volume Forecast, by Material
12.3.6.3. Market Revenue and Volume Forecast, by Indication
12.3.6.4. Market Revenue and Volume Forecast, by End-use
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Type
12.3.7.2. Market Revenue and Volume Forecast, by Material
12.3.7.3. Market Revenue and Volume Forecast, by Indication
12.3.7.4. Market Revenue and Volume Forecast, by End-use
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Type
12.3.8.2. Market Revenue and Volume Forecast, by Material
12.3.8.3. Market Revenue and Volume Forecast, by Indication
12.3.8.4. Market Revenue and Volume Forecast, by End-use
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Type
12.4.2. Market Revenue and Volume Forecast, by Material
12.4.3. Market Revenue and Volume Forecast, by Indication
12.4.4. Market Revenue and Volume Forecast, by End-use
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Type
12.4.5.2. Market Revenue and Volume Forecast, by Material
12.4.5.3. Market Revenue and Volume Forecast, by Indication
12.4.5.4. Market Revenue and Volume Forecast, by End-use
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Type
12.4.6.2. Market Revenue and Volume Forecast, by Material
12.4.6.3. Market Revenue and Volume Forecast, by Indication
12.4.6.4. Market Revenue and Volume Forecast, by End-use
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Type
12.4.7.2. Market Revenue and Volume Forecast, by Material
12.4.7.3. Market Revenue and Volume Forecast, by Indication
12.4.7.4. Market Revenue and Volume Forecast, by End-use
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Type
12.4.8.2. Market Revenue and Volume Forecast, by Material
12.4.8.3. Market Revenue and Volume Forecast, by Indication
12.4.8.4. Market Revenue and Volume Forecast, by End-use
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Type
12.5.2. Market Revenue and Volume Forecast, by Material
12.5.3. Market Revenue and Volume Forecast, by Indication
12.5.4. Market Revenue and Volume Forecast, by End-use
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Type
12.5.5.2. Market Revenue and Volume Forecast, by Material
12.5.5.3. Market Revenue and Volume Forecast, by Indication
12.5.5.4. Market Revenue and Volume Forecast, by End-use
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Type
12.5.6.2. Market Revenue and Volume Forecast, by Material
12.5.6.3. Market Revenue and Volume Forecast, by Indication
12.5.6.4. Market Revenue and Volume Forecast, by End-use
13.1. DePuy Synthes Companies (United States)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Stryker Corporation (United States)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Zimmer Biomet (United States)
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Globus Medical (United States)
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. NuVasive, Inc. (United States)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Alphatec Holdings, Inc. (United States)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Aesculap Implant Systems, LLC (Germany)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Orthofix Holdings, Inc. (United States)
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. AxioMed LLC (United States)
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Spinal Kinetics, Inc. (United States)
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample